Advertisement
Screener

ImmuCell Corporation (ICCC) Long-Term Debt

ImmuCell Corporation Long-Term Debt

ImmuCell Corporation (ICCC) had Long-Term Debt of $6.80 million as of 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation

us-gaap:LongTermDebtNoncurrent · last filed 2026-08-13

  • 2026-06-30: Long-term Debt, Excluding Current Maturities $6.80M.
  • 2026-03-31: Long-term Debt, Excluding Current Maturities $7.07M.
  • 2025-12-31: Long-term Debt, Excluding Current Maturities $7.49M.
  • 2025-09-30: Long-term Debt, Excluding Current Maturities $7.90M.
Period endLong-term Debt, Excluding Current Maturities
2026-06-30$6.80M
10-Q · filed 2026-08-13
2026-03-31$7.07M
10-Q · filed 2026-05-14
2025-12-31$7.49M
10-Q · filed 2026-08-13
2025-09-30$7.90M
10-Q · filed 2025-11-13
2025-06-30$8.26M
10-Q · filed 2025-08-14
2024-12-31$9.04M
10-K · filed 2026-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92